- Open
- 0.57
- High
- 0.60
- Low
- 0.55
- Close
- 0.60
- Change
- -0.02 (-4.35%)
- Volume
- 171,495
⌘K
| 9 Jun 2026 | 07:00:05 | New article: RNA medicine enters its second act |
| 2 Jun 2026 | 08:57:26 | CEO Interview |
| 13 May 2026 | 11:12:34 | CEO Interview: Thalia’s RNA Therapeutics Strategy |
| 20 Apr 2026 | 07:00:04 | Change of Registered Address |
| 19 Jun 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 30 Apr 2024 | Annual Report and Accounts (to 2023-12-31) | |
| 17 May 2023 | Annual Report and Accounts (to 2022-12-31) |
| 9 Jun 2026 | 07:00:05 | New article: RNA medicine enters its second act |
| 2 Jun 2026 | 08:57:26 | CEO Interview |
| 13 May 2026 | 11:12:34 | CEO Interview: Thalia’s RNA Therapeutics Strategy |
| 20 Apr 2026 | 07:00:04 | Change of Registered Address |
| 19 Jun 2025 | Annual Report and Accounts (to 2024-12-31) | |
| 30 Apr 2024 | Annual Report and Accounts (to 2023-12-31) | |
| 17 May 2023 | Annual Report and Accounts (to 2022-12-31) |
| 17 Mar 2026 | 12:14:38 | Result of General Meeting and Change of Name |
| 17 Mar 2026 | 12:14:38 | Result of General Meeting and Change of Name |